Physician profile
Gregory D Searcy
NPI 1528031721
$3,704.05
in general payments reported to CMS, 2019-2025
22 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $239 · 2021: $240 · 2022: $244 · 2023: $361 · 2024: $1,830 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,518 · Food and Beverage: $1,063 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,517.84 |
| Food and Beverage | $1,063.40 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $1,572.33 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Abbvie INC. | $354.10 | 2022-2025 | Durysta, Vuity, Alphagan P |
| Lombart Brothers, INC. | $311.44 | 2019-2020 | |
| Alcon Vision LLC | $198.47 | 2019-2025 | Argos, Tryptyr, Rocklatan |
| Novartis Pharmaceuticals Corporation | $153.56 | 2021-2023 | |
| Emd Serono, INC. | $138.55 | 2024 | Mavenclad |
| Aerie Pharmaceuticals, INC. | $132.81 | 2019-2021 | |
| Allergan, INC. | $128.77 | 2019-2022 | |
| Horizon Therapeutics Plc | $112.91 | 2022-2023 | Tepezza |
| Mallinckrodt Hospital Products INC. | $104.41 | 2020-2024 | Acthar |
| Bausch & Lomb Americas INC. | $85.44 | 2023-2024 | Vyzulta, Miebo |
| Amgen INC. | $70.57 | 2024-2025 | Tepezza |
| Carl Zeiss Meditec, INC. | $64.71 | 2019 | |
| Sun Pharmaceutical Industries INC. | $64.23 | 2020-2025 | |
| Biotissue Holdings INC. | $56.32 | 2023-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $37.80 | 2019-2024 | Tecnis Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.96 | 2021 | |
| Harrow Eye, LLC | $28.28 | 2025 | Vevye |
| New World Medical,INC. | $16.44 | 2023 | |
| Ocular Therapeutix, INC. | $14.82 | 2025 | Dextenza |
| Ivantis, INC | $13.14 | 2020 | |
| Kala Pharmaceuticals, INC. | $12.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Searcy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.